Advanced search    

Search: authors:"Philip E.  Castle"

48 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Social contexts as mediator of risk behaviors in Rwandan men who have sex with men (MSM): Implications for HIV and STI transmission

, Viraj V. Patel, Philip E. Castle, Leon Mutesa, Joel Palefsky, Kathryn M. Anastos. Formal analysis: Adebola Adedimeji, Junaid Chaudhry, Lydia Buzinge, Andre Gitembagara, Gad Murenzi, Viraj V. Patel ... , Philip E. Castle, Joel Palefsky, Kathryn M. Anastos. Funding acquisition: Philip E. Castle, Leon Mutesa, Joel Palefsky, Kathryn M. Anastos. Investigation: Adebola Adedimeji, Brenda Asiimwe-Kateera

A mobile-phone based high-resolution microendoscope to image cervical precancer

?lio Ce?sar Possati-Resende, Cristovam Scapulatempo-Neto, Graziela de Macedo Matsushita, Mark H. Stoler, Philip E. Castle, Jose? Humberto Tavares Guerreiro Fregnani, Kathleen M. Schmeler. Writing

HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico

Xavier Bosch, PhD 4   Jack Cuzick, PhD 5   Attila Lörincz, PhD 5   Cosette M Wheeler, PhD 6   Philip E Castle, PhD 7   Claudia Robles, PhD 4   Eduardo Lazcano-Ponce, DSc 2   1

HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico

Xavier Bosch, PhD 4   Jack Cuzick, PhD 5   Attila Lörincz, PhD 5   Cosette M Wheeler, PhD 6   Philip E Castle, PhD 7   Claudia Robles, PhD 4   Eduardo Lazcano-Ponce, DSc 2   1

Invited Commentary: The Importance of Prevalence in the Effectiveness of a (Bio)marker

Arpita Ghosh 0 Philip E. Castle ) 0 0 Author affiliations: Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute , Bethesda , Maryland (Arpita Ghosh); and ASCP ... Institute , Washington , DC (Philip E. Castle). Conflict of interest: none declared Metrics such as relative hazards and relative risks do not account for the prevalence of a marker over time and its

Response: Re: Preventing Cervical Cancer Globally by Acting Locally: If Not Now, When?

cancer prevention community with a roadmap to sustainable cervical cancer prevention. PHILIP E. CASTLE JULIA C. GAGE Published by Oxford University Press 2011. 1. Farley J , Shin HR , Bray F , Forman D ... cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer . Obstet Gynecol . 2010 ; 116 ( 1 ): 76 - 84 . Notes Correspondence to: Philip E. Castle, PhD, MPH, American Society

The evolving definition of carcinogenic human papillomavirus

Thirteen human papillomavirus (HPV) genotypes have been judged to be carcinogenic or probably carcinogenic, and the cause of virtually all cervical cancer worldwide. Other HPV genotypes could possibly be involved. Although the inclusion of possibly carcinogenic HPV genotypes may hurt test specificity, it may indirectly increase the reassurance following a negative HPV test (i.e...

Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda

Background New World Health Organization guidelines recommend high-risk human papillomavirus (hrHPV) screen-and-treat strategies for cervical cancer prevention. We describe risk of, and risk factors for, testing hrHPV positive in a pilot study of hrHPV screen-and-treat conducted in Rwanda. Methods A total of 2,964 women, 1,289 HIV-infected (HIV [+]) and 1,675 HIV-uninfected (HIV...

Invited Commentary: Is Monitoring of Human Papillomavirus Infection for Viral Persistence Ready for Use in Cervical Cancer Screening?

Philip E. Castle 0 0 From the Division of Cancer Epidemiology and Genetics, National Cancer Institute , Bethesda, MD Persistent cervical infections by approximately 15 carcinogenic genotypes of ... . Correspondence to Dr. Philip E. Castle, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., EPS Room 5004, MSC 7234, Bethesda, MD 20892-7234 (e-mail: ). - Based on the

Human Papillomavirus Prevalence in a Population of Women Living in Port-au-Prince and Leogane, Haiti

BackgroundThere have been no published studies of carcinogenic human papillomavirus (HPV)--the necessary cause of cervical cancer--in Haiti, a nation that has one of the greatest burdens of cervical cancer globally. ObjectiveCharacterize prevalence of carcinogenic HPV and the prevalence of individual carcinogenic HPV genotypes in women with cervical precancer or cancer, cervical...

Human Papillomavirus (HPV) Genotype 84 Infection of the Male Genitalia: Further Evidence for HPV Tissue Tropism?

into these differences could shed light on the mechanism(s) of HPV-induced carcinogenesis. Philip E. Castle Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 1

Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

Primary human papillomavirus (HPV) testing (without concurrent Pap tests) every 3 years is under consideration in the United States as an alternative to the two recommended cervical cancer screening strategies: primary Pap testing every 3 years, or concurrent Pap and HPV testing (“cotesting”) every 5 years. Using logistic regression and Weibull survival models, we estimated and...

Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta

Background There are no data available on human papillomavirus (HPV) infections in women living in the Mississippi Delta, where cervical cancer incidence and mortality among African American women is among the highest in the United States. The aim of this analysis was to report the age-specific prevalence of HPV in this population. Methods We recruited 443 women, 26–65 years of...

A prospective study of age trends of high-risk human papillomavirus infection in rural China

Background In China, high-risk human papillomavirus (HR-HPV) prevalence is unexpectedly high in older women, but the possible reasons have not been well studied yet. This study investigated the age trends of HR-HPV infection in a prospective study. Methods A total of 7397 women aged 25-65 years without cervical precancer or cancer were evaluated during 2010-2011 with a stratified...

A prospective study of age trends of high-risk human papillomavirus infection in rural China

In China, high-risk human papillomavirus (HR-HPV) prevalence is unexpectedly high in older women, but the possible reasons have not been well studied yet. This study investigated the age trends of HR-HPV infection in a prospective study. A total of 7397 women aged 25-65 years without cervical precancer or cancer were evaluated during 2010-2011 with a stratified sample of 2791...

Response: Re: Human Papillomavirus Testing in the Prevention of Cervical Cancer

limited, and the opportunities for benefit so great that all earnest approaches must be welcomed. MARK SCHIFFMAN NICOLAS WENTZENSEN SHOLOM WACHOLDER WALTER KINNEY JULIA C. GAGE PHILIP E. CASTLE

Human Papillomavirus Testing in the Prevention of Cervical Cancer

Mark Schiffman Nicolas Wentzensen Sholom Wacholder Walter Kinney Julia C. Gage Philip E. Castle Strong evidence now supports the adoption of cervical cancer prevention strategies that explicitly

Risk Factors for Anal HPV Infection and Anal Precancer in HIV-Infected Men Who Have Sex With Men

Background. Carcinogenic human papillomaviruses (HPVs) cause a large proportion of anal cancers. Human immunodeficiency virus (HIV)–infected men who have sex with men (MSM) are at increased risk of HPV infection and anal cancer compared with HIV-negative men. We evaluated risk factors for HPV infection and anal precancer in a population of HIV-infected MSM. Methods. Our study...

Re: Human Papillomavirus in Oral Exfoliated Cells and Risk of Head and Neck Cancer

papillomavirus type 16 vaccine. N Engl J Med 2002;347:164551. NOTES Correspondence to: Philip E. Castle, PhD, MPH, Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics ... potential of these vaccines for preventing HPV infections of the head and neck, confirm the causal link between HPV16 infection and HNSCC, and provide a much needed intervention for these patients. PHILIP E